Kukje Pharma Co Ltd (002720) — Cash Flow Reinvestment Rate
Kukje Pharma Co Ltd (002720) has a Cash Flow Reinvestment Rate of 0.10x as of September 2025, reinvesting ₩474.52 Million (capex ₩474.52 Million ) from operating cash flow of ₩4.99 Billion. Explore Kukje Pharma Co Ltd (002720) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kukje Pharma Co Ltd Cash Flow Reinvestment Rate (2011–2024)
Historical reinvestment intensity for Kukje Pharma Co Ltd across 11 annual periods. Also explore 002720 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Kukje Pharma Co Ltd (2011–2024)
Year-by-year capital reinvestment analysis for Kukje Pharma Co Ltd. For live market cap and broader valuation context, see 002720 company net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.20x | ₩4.74 Billion | ₩3.94 Billion | ₩2.99 Billion | ▲ +248.0% |
| 2023 | 0.35x | ₩1.24 Billion | ₩3.58 Billion | ₩1.05 Billion | ▼ -13.7% |
| 2022 | 0.40x | ₩2.61 Billion | ₩6.50 Billion | ₩1.26 Billion | ▲ +18.2% |
| 2021 | 0.34x | ₩3.25 Billion | ₩9.60 Billion | ₩1.89 Billion | ▼ -87.5% |
| 2020 | 2.71x | ₩13.80 Billion | ₩5.10 Billion | ₩11.60 Billion | ▲ +39.2% |
| 2019 | 1.94x | ₩7.01 Billion | ₩3.60 Billion | ₩5.89 Billion | ▲ +510.6% |
| 2018 | 0.32x | ₩4.22 Billion | ₩13.25 Billion | ₩3.03 Billion | ▼ -94.4% |
| 2017 | 5.65x | ₩4.44 Billion | ₩786.10 Million | ₩2.61 Billion | ▲ +1090.8% |
| 2016 | 0.47x | ₩7.63 Billion | ₩16.10 Billion | ₩2.69 Billion | ▼ -52.8% |
| 2012 | 1.00x | ₩1.59 Billion | ₩1.58 Billion | ₩1.59 Billion | ▲ +1641.9% |
| 2011 | 0.06x | ₩1.00 Billion | ₩17.39 Billion | ₩1.00 Billion | — |